Atara Biotherapeutics (ATRA) Q2 2023 Earnings Report
0 Followers
CH:ATRA Q2 2023 EPS Results
- Actual EPS
- -CHF 13.89
- Consensus EPS
- -CHF 13.40
- Beat/Miss
- Missed by -CHF 0.49
- One Year Ago EPS
- CHF 3.68
CH:ATRA Q2 2023 Revenue Results
- Actual Revenue
- CHF 781.96K
- Expected Revenue
- CHF 3.56M
- Beat/Miss
- Missed by -CHF 2.78M
- YoY Revenue Growth
- -98.14%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/08/2023
- Time
- After Close
- Conference Call
- Tuesday, August 8, 2023
CH:ATRA Upcoming Earnings
Atara Biotherapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ATRA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | ―- | -0.2 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.11- | -0.26 | ― | |
| Aug 12, 2026 | 2026 (Q2) | -0.26-0.26 | 0.16 | -268.42% (-0.42) | |
| May 12, 2026 | 2026 (Q1) | -0.27-0.24 | 2.86 | -108.29% (-3.10) | |
| Mar 16, 2026 | 2025 (Q4) | -0.14-0.20 | -0.97 | 78.99% (+0.77) | |
| Nov 29, 2025 | 2025 (Q3) | -0.54-0.26 | -2.39 | 89.08% (+2.13) | |
| Aug 11, 2025 | 2025 (Q2) | -0.050.16 | -2.53 | 106.13% (+2.69) | |
| May 15, 2025 | 2025 (Q1) | -1.622.86 | -4.7 | 160.87% (+7.56) | |
| Mar 07, 2025 | 2024 (Q4) | -2.34-0.97 | -11.44 | 91.50% (+10.47) | |
| Nov 12, 2024 | 2024 (Q3) | -1.54-2.39 | -13.48 | 82.24% (+11.09) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
